| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 4 | 89 | 0.89 | 1.39 | BLENDED GS |
| May 2025 | 54 | 89 | -1.58 | 2.72 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 4 | 89 | 0.89 | 1.39 | BLENDED GS |
| May 2025 | 54 | 89 | -1.58 | 2.72 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 320 | 121 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 121 | 322 | 7240 | 399 | 394 | 83 | 81 |
| May 2025 | 122 | 322 | 7200 | 399 | 395 | 83 | 81 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 121 | 322 | 7240 | 399 | 394 | 83 | 81 |
| May 2025 | 122 | 322 | 7200 | 399 | 395 | 83 | 81 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 309 | 268 | 204 | 130 | 78 |
| No. Herds | 109 | 111 | 92 | 71 | 53 |
| No. without completed record | 4 | 3 | 5 | 19 | 13 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 309 | 268 | 204 | 130 | 78 |
| No. Herds | 109 | 111 | 92 | 71 | 53 |
| No. without completed record | 4 | 3 | 5 | 19 | 13 |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 320 | 121 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | 0 | 0 | 0 | 0 |
| CAN | 61 | 42 | 82 | 48 |
| DFS | 30 | 15 | 25 | 11 |
| FRA | 0 | 0 | 0 | 0 |
| GBR | 601 | 177 | 782 | 210 |
| GER | 90 | 52 | 130 | 60 |
| ITA | 84 | 44 | 89 | 47 |
| NLD | 25 | 16 | 35 | 22 |
| NZL | 0 | 0 | 0 | 0 |
| USA | 0 | 0 | 320 | 149 |